| Protein tyrosine phosphatase-1B inhibition disrupts IL13Rα2-promoted invasion and metastasis in cancer cells RA Bartolomé, Á Martín-Regalado, M Jaén, M Zannikou, P Zhang, ... Cancers 12 (2), 500, 2020 | 32 | 2020 |
| An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer RA Bartolomé, M Jaén, JI Casal British Journal of Cancer 119 (8), 940-949, 2018 | 30 | 2018 |
| SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166 RA Bartolomé, L Pintado-Berninches, M Jaén, V de Los Ríos, JI Imbaud, ... Oncogene 39 (38), 6085-6098, 2020 | 24 | 2020 |
| Monoclonal antibodies directed against cadherin RGD exhibit therapeutic activity against melanoma and colorectal cancer metastasis RA Bartolomé, C Aizpurua, M Jaén, S Torres, E Calviño, JI Imbaud, ... Clinical Cancer Research 24 (2), 433-444, 2018 | 24 | 2018 |
| PAUF/ZG16B promotes colorectal cancer progression through alterations of the mitotic functions and the Wnt/β-catenin pathway B Escudero-Paniagua, RA Bartolomé, S Rodríguez, V De los Ríos, ... Carcinogenesis 41 (2), 203-213, 2020 | 21 | 2020 |
| CDH6‐activated αIIbβ3 crosstalks with α2β1 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers RA Bartolomé, J Robles, Á Martin‐Regalado, L Pintado‐Berninches, ... Molecular Oncology 15 (7), 1849-1865, 2021 | 18 | 2021 |
| Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer M Jaén, Á Martín-Regalado, RA Bartolomé, J Robles, JI Casal Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (5), 188802, 2022 | 16 | 2022 |
| Inhibition of liver metastasis in colorectal cancer by targeting IL-13/IL13Rα2 binding site with specific monoclonal antibodies M Jaén, RA Bartolomé, C Aizpurua, Á Martin-Regalado, JI Imbaud, ... Cancers 13 (7), 1731, 2021 | 9 | 2021 |
| A prognostic six‐gene expression risk‐score derived from proteomic profiling of the metastatic colorectal cancer secretome J Robles, L Pintado‐Berninches, I Boukich, B Escudero, V de Los Rios, ... The Journal of Pathology: Clinical Research 8 (6), 495-508, 2022 | 3 | 2022 |
| Antibody and use thereof for the treatment of cancer JI Casal, RÁ Bartolomé, M Jaén | | 2022 |
| Looking for novel interactors of IL-13 receptor α2 (IL13Rα2) and tyrosine-protein phosphatase non-receptor type 1 (PTPN1/PTP1B) by using proximity-dependent biotinylation (BioID) Á Martin-Regalado, RÁ Bartolomé, J Robles, M Jaén, ... | | 2022 |
| CDH17 as a biomarker and target of chemoresistance to irinotecan M Jaén, RÁ Bartolomé, L Pintado-Berninches, Á Martin-Regalado, ... | | 2022 |
| Characterization of cadherin 6 as a novel therapeutic target in metastatic ovarian carcinoma M Burdiel, R Bartolomé, M Jaén, I Casal Cancer Research 79 (13_Supplement), 2850-2850, 2019 | | 2019 |
| Protein-tyrosine phosphatase 1B (PTP1B) as a therapeutic target in glioblastoma R Bartolomé, M Jaén, M Burdiel, IV Balyasnikova, I Casal Cancer Research 79 (13_Supplement), 253-253, 2019 | | 2019 |
| Unraveling the “dark” proteome in cancer metastasis JI Casal, RÁ Bartolomé, M Jaén, L Pintado-Berninches, ... Fundación General de la Universidad de Alcalá, 2019 | | 2019 |
| An IL13Rα2 peptide inhibits colorectal cancer metastatic progression I Casal, M Jaén, RA Bartolomé Cancer Research 78 (13_Supplement), 4177-4177, 2018 | | 2018 |
| Abstract B047: A novel and efficient therapeutic strategy to target β1 integrin in metastatic cells from different cancer types I Casal, RA Bartolomé, M Jaén, C Aizpurua, E Calviño, JI Imbaud Molecular Cancer Therapeutics 17 (1_Supplement), B047-B047, 2018 | | 2018 |
